Different Expressed Locations of Cancer Stem Cell Markers CD133 and CD44 in Well Differentiated Gastric Cancer and Adenoma

被引：1
|
作者：
Shibata, Tomoyuki
Kamatani, Akemi
Nakamura, Masakatsu
Tahara, Tomomitsu
Hirata, Ichiro
机构：
来源：
GASTROENTEROLOGY | 2011年 / 140卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
引用
收藏
页码：S320 / S320
页数：1
相关论文
共 50 条
  • [21] CD133, CD44, and ALDH1A1 as cancer stem cell markers and prognostic factors in epithelial ovarian cancer
    Pelupessy, Nugraha Utama
    Andrijono
    Sutrisna, Bambang
    Harahap, Alida Roswita
    Kanoko, Mpu
    Nuranna, Laila
    Siregar, Budiningsih
    Wulandari, Dewi
    MEDICAL JOURNAL OF INDONESIA, 2019, 28 (01) : 63 - 69
  • [22] CD44 and CD133 aptamer directed nanocarriers for cancer stem cells targeting
    Grover, Rakshita
    Drall, Sahil
    Poonia, Neelam
    Jain, Gaurav Kumar
    Aggarwal, Geeta
    Lather, Viney
    Kesharwani, Prashant
    Pandita, Deepti
    Goyal, Ramesh K.
    EUROPEAN POLYMER JOURNAL, 2023, 183
  • [23] Co-expression of CD44 and CD133 as cancer stem cells (CSC) markers in prostate cancer (PCa) tissue
    Puchinskaya, M.
    ANNALS OF ONCOLOGY, 2021, 32 : S1369 - S1369
  • [24] The promotion of nanoparticle delivery to two populations of gastric cancer stem cells by CD133 and CD44 antibodies
    Chen, Han
    Lin, Jiajia
    Shan, Yongqi
    Lu, Zhengmao
    BIOMEDICINE & PHARMACOTHERAPY, 2019, 115
  • [25] Clinicopathological and prognostic significance of cancer stem cell markers CD44 and CD133 in patients with gastric cancer A comprehensive meta-analysis with 4729 patients involved
    Lu, Li
    Wu, Menglin
    Sun, Longhao
    Li, Weidong
    Fu, Weihua
    Zhang, Xuening
    Liu, Tong
    MEDICINE, 2016, 95 (42)
  • [26] Prognostic impact of the expression of cancer stem cell markers CD166, CD44, EpCAM, ALDH1 and CD133 in colorectal cancer
    lezzi, Giandomenica
    Lugli, Alessandro
    Muraro, Manuele G.
    Mele, Valentina
    Hostettler, Isabel
    Tornillo, Luigi
    Carafa, Vincenza
    Spagnoli, Giulio C.
    Terracciano, Luigi
    Zlobec, Intl
    CANCER RESEARCH, 2010, 70
  • [27] Evaluation of Cancer Stem Cell Markers CD133, CD44, CD24: Association with AKT Isoforms and Radiation Resistance in Colon Cancer Cells
    Sahlberg, Sara Haggblad
    Spiegelberg, Diana
    Glimelius, Bengt
    Stenerlow, Bo
    Nestor, Marika
    PLOS ONE, 2014, 9 (04):
  • [28] Expression of CD44 and CD133 markers in regional metastases from breast cancer.
    Sagakyants, Aleksandr B.
    Ulianova, Elena P.
    Zlatnik, Elena Yu
    Novikova, Inna A.
    Shulgina, Oksana G.
    Karnaukhov, Nikolay S.
    Kuznetsova, Marina A.
    Petriashvili, Inna R.
    Gaysultanova, Yakha S.
    Vladimirova, Liubov Yu
    Shatova, Iuliana S.
    Vashchenko, Larisa N.
    Lisutin, Aleksandr E.
    Kit, Oleg, I
    JOURNAL OF CLINICAL ONCOLOGY, 2020, 38 (15)
  • [29] Expression of putative cancer stem cell markers CD44 and CD133 in prostate carcinomas: A tissue microarray study of Iranian patients
    Asgari, M.
    Kalantari, E.
    Nikpanah, S.
    Salarieh, N.
    Madjd, Z.
    VIRCHOWS ARCHIV, 2016, 469 : S227 - S228
  • [30] Cancer Stem Cell Markers — CD133 and CD44 — in Paediatric Solid Tumours: A Study of Immunophenotypic Expression and Correlation with Clinicopathological Parameters
    Shashikant Singh
    Minakshi Bhardwaj
    Amita Sen
    Kaniyappan Nambiyar
    Arvind Ahuja
    Indian Journal of Surgical Oncology, 2023, 14 : 113 - 121
12345